RPRX
Royalty Pharma Plc Class A · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website royaltypharma.com
- Employees(FY) -
- ISIN GB00BMVP7Y09
Performance
+1.05%
1W
-4.11%
1M
-3.9%
3M
+3.08%
6M
+0.34%
YTD
-19.02%
1Y
Profile
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Investment Analysis Report: RPRX
Overview
In this investment analysis report, we will delve into the financial statements of RPRX, a company operating in the Health Technology sector within the Pharmaceuticals: Major industry. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operating ...
Technical Analysis of RPRX 2024-05-03
Overview:
In analyzing the technical indicators for RPRX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for potential invest...
Recent News & Updates
- 2024-05-05 21:16
- 2024-05-04 08:49
Royalty Pharma's (NASDAQ:RPRX) Dividend Will Be $0.21(Simply Wall St.)
- 2024-05-02 04:01
- 2024-05-01 22:01
- 2024-04-29 20:37
- 2024-04-20 08:29
Royalty Pharma (NASDAQ:RPRX) Will Pay A Dividend Of $0.21(Simply Wall St.)
- 2024-04-19 08:15
- 2024-04-18 20:15
- 2024-04-17 08:15
Royalty Pharma Declares Second Quarter 2024 Dividend(GlobeNewswire)
- 2024-04-16 20:15
Royalty Pharma Declares Second Quarter 2024 Dividend(Globenewswire)
- 2024-03-30 09:00
- 2024-03-16 20:50
30 Biggest Biotechnology Companies in the World(Insidermonkey)
- 2024-02-28 16:15
- 2024-02-28 03:15
- 2024-02-20 12:45
Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover(Morningstar Research)
- 2024-02-18 07:11
- 2024-02-17 07:09
- 2024-02-17 00:15
Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover(Morningstar Research)
- 2024-02-16 02:30
- 2024-02-16 00:04
Royalty Pharma PLC (RPRX): A Strategic SWOT Insight(GuruFocus.com)
- 2024-02-15 23:08
Analyst Report: Royalty Pharma plc(Morningstar Research)
- 2024-02-15 20:45
- 2024-02-15 07:30
Royalty Pharma Reports Q4 and Full Year 2023 Results(GlobeNewswire)
- 2024-02-14 18:58
- 2024-02-14 18:30
Royalty Pharma Reports Q4 and Full Year 2023 Results(Globenewswire)
- 2024-01-30 16:15
- 2024-01-30 12:04
What Makes Royalty Pharma plc (RPRX) a Compelling Stock?(Insidermonkey)
- 2024-01-30 03:15
- 2024-01-22 05:24
- 2024-01-19 08:15
Royalty Pharma Announces Dividend Increase(GlobeNewswire)
Page 1 of 5
previousnext